1
|
Brun A, Koutlidis N, Thibault T, Escoffier A, Bardet F, Cormier L. [The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer]. Prog Urol 2023; 33:125-134. [PMID: 36604247 DOI: 10.1016/j.purol.2022.12.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 12/07/2022] [Accepted: 12/19/2022] [Indexed: 01/05/2023]
Abstract
INTRODUCTION Restaging transurethral resection (re-TUR) of high grade T1 bladder cancer (HGT1-BC) is recommended but the impact in terms of recurrence-free survival (RFS) and progression-free survival (PFS) is discussed. The objective of this study was to evaluate our practice of re-TUR for these tumors and its impact on overall survival (OS), RFS and PFS. MATERIALS AND METHODS A retrospective observational study was conducted between 2010 and 2020. The inclusion criteria was the presence of newly diagnosed HGT1-BC. Patients with incomplete resection, suspicion of infiltrating tumor, upper tract urothelial cancer, or metastatic disease were ineligible. Two groups were defined : Group 1 with re-TUR and Group 2 without re-TUR. RFS and PFS were evaluated. RESULTS A total of 78 patients were included, including 50 (64,1%) in group 1. There were no significant differences between the two groups. The mean time to re-TUR was 8 weeks and 60% residual tumor was found. Initial under-staging was found in 12% of cases. RFS and PFS were significantly better in Group 1 (P=0.0019; P=0,02). No significant were found between the groups in OS and specific survival (SS). CONCLUSION Performing a re-TUR for high grade T1 bladder tumors allows detection of residual tumor and decreases the risk of under-evaluation. It is associated with a significant improvement in RFS and PFS with no impact on OS and SS. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- A Brun
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand, Dijon, France; Service d'urologie, centre hospitalier William Morey, Chalon sur Saône, France.
| | - N Koutlidis
- Service d'urologie, centre hospitalier William Morey, Chalon sur Saône, France
| | - T Thibault
- Service de médecine interne, centre hospitalier universitaire Francois-Mitterrand, Dijon, France
| | - A Escoffier
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand, Dijon, France
| | - F Bardet
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand, Dijon, France
| | - L Cormier
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand, Dijon, France
| |
Collapse
|
2
|
Paturel P, Bardet F, Cormier L, Mourey E. [Neurogenic bladder and continent cystostomy: Results of a monocentric cohort in a French university hospital]. Prog Urol 2021; 32:23-31. [PMID: 34256991 DOI: 10.1016/j.purol.2021.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 03/18/2021] [Accepted: 04/02/2021] [Indexed: 11/29/2022]
Abstract
OBJECTIVE The main objective was to evaluate the complications of continuous urinary shunts in a French university hospital according to surgical technique and functional results especially on continence. The secondary objective was to evaluate the management of complications. METHODS A retrospective study was conducted between January 2008 and August 2017. Patients who had a continent cystostomy with or without bladder augmentation were included. Diversions for non-neurological causes were excluded. Cystostomy was performed using the appendix or a Monti's artifice. Data collected included complications and their management, functionality of the diversion and of the bladder reservoir, cystostomy continence, and urethral continence. RESULTS Nineteen patients were included. The median follow-up time was 46 months. The majority of early postoperative complications were classified as grade II Clavien-Dindo. No postoperative deaths occurred. Late complications most frequently involved cystostomy duct stenosis (n=5), cystostomy incontinence (n=5), and urethral incontinence (n=8). Thirteen patients had revision surgery for late complications. Late complications on continence evolved favorably after revision surgery or medical treatment in all, but one case. CONCLUSION Our results are consistent with the literature. Complications and the re-interventions are frequent and should lead to a multidisciplinary information and evaluation of the patient in preoperative care. LEVEL OF PROOF 3.
Collapse
Affiliation(s)
- P Paturel
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand Dijon, centre hospitalier Robert-Morlevat Semur-en-Auxois, 14, rue Paul-Gaffarel, 21000 Dijon, France.
| | - F Bardet
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand Dijon, centre hospitalier Robert-Morlevat Semur-en-Auxois, 14, rue Paul-Gaffarel, 21000 Dijon, France
| | - L Cormier
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand Dijon, centre hospitalier Robert-Morlevat Semur-en-Auxois, 14, rue Paul-Gaffarel, 21000 Dijon, France
| | - E Mourey
- Service d'urologie et andrologie, centre hospitalier universitaire François-Mitterrand Dijon, centre hospitalier Robert-Morlevat Semur-en-Auxois, 14, rue Paul-Gaffarel, 21000 Dijon, France
| |
Collapse
|
3
|
Rozet F, Mongiat-Artus P, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mathieu R, Ploussard G, Renard-Penna R, Brenot-Rossi I, Bruyere F, Cochet A, Crehange G, Cussenot O, Lebret T, Rebillard X, Soulié M, Brureau L, Méjean A. Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251]. Prog Urol 2021; 31:381-382. [PMID: 33941457 DOI: 10.1016/j.purol.2021.04.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- F Rozet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France; Institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.
| | - P Mongiat-Artus
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - C Hennequin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - J B Beauval
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - P Beuzeboc
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Cormier
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Fromont-Hankard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Mathieu
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Ploussard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Renard-Penna
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - I Brenot-Rossi
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - F Bruyere
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Cochet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Crehange
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - O Cussenot
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - T Lebret
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - X Rebillard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - M Soulié
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Brureau
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| |
Collapse
|
4
|
Bardet F, Sejourné L, Mourey E, Thibaud D, Cormier L. Réalisation des biopsies de prostate en 2019 : enquête de pratique auprès des urologues français. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
5
|
Vallée M, Mallet R, Cormier L, Mongiat-Artus P, Fournier G, Gamé X, Bruyère F, Pradère B. Organisation de la téléconsultation en chirurgie urologique durant l’épidémie de COVID-19. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
6
|
Lamboley Y, Schneider A, Bardet F, Sejourne L, Cormier L. Facteurs de risque de complication après photovaporisation laser Greenlight. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Rozet F, Hennequin C, Beuzeboc P, Mathieu R, Mongiat-Artus P, Beauval JB, Cormier L, Fromont-Hankard G, Ploussard G, Renard-Penna R, Brureau L, Méjean A. [French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020]. Prog Urol 2020; 30:430-438. [PMID: 32517891 DOI: 10.1016/j.purol.2020.04.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 04/13/2020] [Accepted: 04/14/2020] [Indexed: 11/27/2022]
Abstract
OBJECTIVE The aim of the Cancerology Committee of the French Association of urology (CCAFU) is to propose an update of the guidelines in the management of hormone-sensitive metastatic prostate cancer. METHODS A systematic review (Medline) of the literature from 2018 to 2020 was conducted by the CCAFU Findings. Several patterns can be defined at this stage depending on prognostic, metastatic volume, and whether metastases are synchronous or metachronous. Androgenic deprivation therapy (ADT) remains the mainstay of treatment at the metastatic stage. Docetaxel in combination with ADT improves overall survival in synchronous metastatic prostate cancer. In this situation, the combination of ADT with abiraterone is also a standard of care regardless of tumor volume. Recent data have led to the recommendation that ADT should be used in conjunction with a new generation hormone therapy (Apalutamide or Enzalutamide) in metastatic synchronous or metachronous patients, regardless of tumour volume. Local treatment of prostate cancer with radiotherapy improves survival in synchronous oligometastatic patients. Metastases-directed therapy is being evaluated. CONCLUSION This update of the French recommendations should help improve the management of patients with prostate cancer.
Collapse
Affiliation(s)
- F Rozet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France.
| | - C Hennequin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - P Beuzeboc
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Mathieu
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - P Mongiat-Artus
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - J-B Beauval
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Cormier
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Fromont-Hankard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Ploussard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Renard-Penna
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Brureau
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017 Paris, France
| |
Collapse
|
8
|
Bardet F, Frontczak A, Schneider A, Delattre B, Kleinclauss F, Cormier L. IRM de prostate et dépistage : enquête de la pratique auprès des médecins généralistes de Bourgogne-Franche-Comté. Prog Urol 2019; 29:974-980. [DOI: 10.1016/j.purol.2019.09.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2019] [Revised: 06/13/2019] [Accepted: 09/25/2019] [Indexed: 10/25/2022]
|
9
|
Bardet F, Leclercq V, Delattre B, Schneider A, Mignot G, Mourey E, Cormier L. Amélioration de la prédiction du score ISUP définitif par l’apport des biopsies ciblées avec fusion logicielle. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Hutin M, Thezenas S, Timsit M, Pettenati C, Gallon J, Karam G, Branchereau J, Heldhli O, Badet L, Matillon X, Salomon L, Cholley I, Bessede T, Neuzillet Y, Robert G, Bensadoun H, Allenet C, Cormier L, Schneider A, Leclercq V, Sallusto F, Descazeaud A, Peyronnet B, Hascoet J, Bouye S, Lechevallier E, Delaporte V, Lannes F, Boutin J, Berthelot L, Iborra F, Thuret R. Incidence et morbi-mortalité des tumeurs de la voie excrétrice du transplant après transplantation rénale : étude multicentrique française. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Papillon F, Cormier L, Legeais D. [Medico-legal risk in urology: Analysis of a portfolio of insured persons by a French insurance company between 2009 and 2018]. Prog Urol 2018; 29:18-28. [PMID: 30448010 DOI: 10.1016/j.purol.2018.10.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Revised: 10/05/2018] [Accepted: 10/11/2018] [Indexed: 11/29/2022]
Abstract
OBJECTIVE Presentation of data collected on urology claims from the register of a French insurance company. MATERIAL AND METHOD Compensation claims involving urologists covering the period 2009-2018 were identified and analyzed. RESULTS A total of 37 files were found. Oncological and functional surgical interventions accounts for 78% of repair claims. Postoperative complications represent 76% of the cases. The most represented acts are total prostatectomy (5) and promonto-fixation (4). The average time of complaint is 28.6 months [1-144 months], the average duration of a procedure (opening-closing) is 32.8 months [12-72 months]. The Conciliation and Compensation Commissions (CCC) and the High Court Courts (HCC) were solicited respectively in 51% and 33% of the proceedings. An amicable agreement is found in 16% of cases. There was no criminal or disciplinary proceedings. The average cost of a closed urology file is 7836 € [0-31,120 €]. In total, 64.8% of the expertises confirm practices in the respect of the rules of the art. CONCLUSION This series presents the first forensic analysis of a portfolio of urologists on a period of 9 years in French urology. There is a rate of responsibility retained against the practitioner in only 27% of cases. The low rate of faulty files, the absence of a conviction for breach of the duty to provide information and in connection with antibiotic prophylaxis seem to confirm that the practice of urology in France is of good quality, a further study on a longer period of time and on a larger cohort of urologists would allow a finer medico-legal approach. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- F Papillon
- Service d'urologie, CHU François-Mitterrand, 2, avenue du Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France.
| | - L Cormier
- Service d'urologie, CHU François-Mitterrand, 2, avenue du Maréchal-de-Lattre-de-Tassigny, 21000 Dijon, France.
| | - D Legeais
- Service d'urologie, clinique d'Alembert, 124, rue d'Alembert, 38000 Grenoble, France.
| |
Collapse
|
12
|
Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Penna RR, Méjean A. RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer. Prog Urol 2018; 28:S79-S130. [PMID: 30392712 DOI: 10.1016/j.purol.2018.08.011] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Accepted: 08/14/2018] [Indexed: 12/31/2022]
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
Cet article est retiré de la publication à la demande des auteurs car ils ont apporté des modifications significatives sur des points scientifiques après la publication de la première version des recommandations.
Le nouvel article est disponible à cette adresse: DOI:10.1016/j.purol.2019.01.007.
C’est cette nouvelle version qui doit être utilisée pour citer l’article.
This article has been retracted at the request of the authors, as it is not based on the definitive version of the text because some scientific data has been corrected since the first issue was published.
The replacement has been published at the DOI:10.1016/j.purol.2019.01.007.
That newer version of the text should be used when citing the article.
Collapse
Affiliation(s)
- F Rozet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, institut mutualiste Montsouris, université René-Descartes, 42, boulevard Jourdan, 75674, Paris, France.
| | - C Hennequin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service de radiothérapie, Saint-Louis Hospital, AP-HP, 75010, Paris, France
| | - J-B Beauval
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, oncologie médicale, institut universitaire du cancer Toulouse-Oncopole, CHU Rangueil, 31100, Toulouse, France
| | - P Beuzeboc
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Foch, 92150, Suresnes, France
| | - L Cormier
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, CHU François-Mitterrand, 21000, Dijon, France
| | - G Fromont-Hankard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; CHU de Tours, 2, boulevard Tonnellé, 37000, Tours, France
| | - P Mongiat-Artus
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, Paris cedex 10, France
| | - G Ploussard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, clinique La Croix du Sud-Saint-Jean Languedoc, institut universitaire du cancer, 31100, Toulouse, France
| | - R Mathieu
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital de Rennes, 2, rue Henri-le-Guilloux, 35033, Rennes cedex 9, France
| | - L Brureau
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Inserm, U1085, IRSET, 97145 Pointe-à-Pitre, Guadeloupe
| | - A Ouzzane
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Claude-Huriez, CHRU de Lille, rue Michel-Polonovski, 59000, Lille, France
| | - D Azria
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Inserm U1194, ICM, université de Montpellier, 34298, Montpellier, France
| | - I Brenot-Rossi
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, 13009, Marseille, France
| | - G Cancel-Tassin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; GRC no 5 ONCOTYPE-URO, institut universitaire de cancérologie, Sorbonne université, 75020, Paris, France
| | - O Cussenot
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Tenon, AP-HP, Sorbonne université, 75020, Paris, France
| | - X Rebillard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, clinique mutualiste Beau-Soleil, 119, avenue de Lodève, 34070, Montpellier, France
| | - T Lebret
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital Foch, 92150, Suresnes, France
| | - M Soulié
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Centre hospitalier universitaire Rangueil, 31059, Toulouse, France
| | - R Renard Penna
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; GRC no 5 ONCOTYPE-URO, institut universitaire de cancérologie, Sorbonne université, 75020, Paris, France; Service de radiologie, hôpital Tenon, AP-HP, 75020, Paris, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, maison de l'urologie, 11, rue Viète, 75017, Paris, France; Service d'urologie, hôpital européen Georges-Pompidou, université Paris Descartes, Assistance publique des hôpitaux de Paris (AP-HP), 75015, Paris, France
| |
Collapse
|
13
|
Sejourne L, Bardet F, Papillon F, Cormier L. Applicabilité du score de Briganti dans la décision de curage ganglionnaire dans le cancer de la prostate. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Renard Penna R, Méjean A. Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate. Prog Urol 2018; 28 Suppl 1:R81-R132. [DOI: 10.1016/j.purol.2019.01.007] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Accepted: 08/14/2018] [Indexed: 01/02/2023]
|
15
|
Antle DM, Cormier L, Findlay M, Miller LL, Côté JN. Lower limb blood flow and mean arterial pressure during standing and seated work: Implications for workplace posture recommendations. Prev Med Rep 2018; 10:117-122. [PMID: 29850397 PMCID: PMC5966524 DOI: 10.1016/j.pmedr.2018.02.016] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2017] [Revised: 02/13/2018] [Accepted: 02/26/2018] [Indexed: 11/23/2022] Open
Abstract
Sit-stand workstations are a popular workplace intervention. Organizations often require a medical professional's guidance for implementation. Therefore, it is important to understand potential negative outcomes associated with standing work, such as lower limb discomfort and peripheral vascular issues. The objective of this study was to compare changes in lower limb discomfort, blood pressure and blood flow accumulation during a light-load repetitive upper limb work task accomplished from seated and standing postures. At the Jewish Rehabilitation Hospital (Laval, Quebec, Canada), 16 participants were outfitted with Laser Doppler Flow (LDF) electrodes to measure blood flow in the lower limb, and a sphygmomanometer to measure lower limb mean arterial blood pressure (MAP). Participants completed simulated work over 34 min in standing and seated conditions. Repeated measures ANOVAs (Posture x Time) were used to assess the differences. There were significant effects for both Posture (p = 0.003) and Time (p = 0.007) for LDF-measured of blood flow accumulation in the soleus and the foot, with a mean increase of 77% blood flow over time in the standing posture, when compared to seated work. There was a significant 'Posture × Time' (p = 0.0034) interaction effect and a significant Posture (p = 0.0001) effect for MAP, with higher values in the standing posture by a mean of 37.2 mmHg. Posture had a significant effect (p < 0.001) on lower limb discomfort, with standing posture reporting higher levels. These results suggest that recommendations for using static standing work postures should be tempered, and physicians' guidance on workstation changes should consider the impacts on the lower limb.
Collapse
Affiliation(s)
- David M. Antle
- Department of Kinesiology and Physical Education, McGill University, Montréal, QC, Canada
- MD Program, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - Lauren Cormier
- MD Program, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | - Megan Findlay
- MD Program, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
| | | | - Julie N. Côté
- Department of Kinesiology and Physical Education, McGill University, Montréal, QC, Canada
| |
Collapse
|
16
|
Rozet F, Hennequin C, Mongiat-Artus P, Beuzeboc P, Beauval JB, Cormier L, Fromont-Hankard G, Ouzzane A, Ploussard G, Renard-Penna R, Méjean A. Recommandations françaises du comité de cancérologie de l’AFU pour le cancer de la prostate : cancer de prostate métastatique hormono-naïf – actualisation 2017. Prog Urol 2018; 28:303-306. [DOI: 10.1016/j.purol.2018.03.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2018] [Accepted: 03/17/2018] [Indexed: 10/17/2022]
|
17
|
Crehange G, Cormier L, Bertaut A, Peiffert D, Bolla M, Chapet O, Rio E, De Crevoisier R, Martin E, Cosset J. EP-1581: Salvage brachytherapy and a rectal spacer in locally recurrent prostate cancer after radiotherapy. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31890-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
18
|
Caubet M, Pasquier D, Bertaut A, Grobois S, De Bari B, Kleinclauss F, Thiery-Vuillemin A, Martin E, Quivrin M, Cormier L, Créhange G. EP-1585: Whole pelvic nodal radiotherapy (RT) vs. prostate bed RT after prostatectomy for prostate cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31894-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
19
|
Phan QB, Mourey E, Estivalet L, Delattre B, Bardet F, Chevallier O, Louis D, Aho L, Loffroy R, Cormier L. Reliability and reproducibility of the American Association for the Surgery of Trauma scaling for renal injury and impact on radiologic follow-up. Prog Urol 2018; 28:12-17. [DOI: 10.1016/j.purol.2017.09.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2017] [Revised: 09/12/2017] [Accepted: 09/26/2017] [Indexed: 11/29/2022]
|
20
|
Callerot P, Valeri A, Fournier G, Moineau M, Cussenot O, Doucet L, Cancel-tassin G, Cormier L. Dépistage du cancer de la prostate dans les familles à risque. Le nombre d’apparentés atteints et l’âge précoce de diagnostic dans la famille augmentent le risque de CaP. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
21
|
Mathe N, Alghamdi A, Cormier L, Avedzi H, Butalia S, Davenport MH, Johnson JA, Johnson ST. Lifestyle Behaviours Following Gestational Diabetes Mellitus. Can J Diabetes 2017. [DOI: 10.1016/j.jcjd.2017.08.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
22
|
Ingstrup M, Wozniak LA, Mathe N, Alghamdi A, Cormier L, Butalia S, Davenport MH, Johnson JA, Johnson ST. Established Social Support Systems Trumps Peer Counselling Support in Helping Women who Experienced Gestational Diabetes Adhere to Healthy Lifestyle Changes. Can J Diabetes 2017. [DOI: 10.1016/j.jcjd.2017.08.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Zanatta M, Cormier L, Hennet L, Petrillo C, Sacchetti F. Real-time observation of the isothermal crystallization kinetics in a deeply supercooled liquid. Sci Rep 2017; 7:43671. [PMID: 28255173 PMCID: PMC5334641 DOI: 10.1038/srep43671] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2016] [Accepted: 01/26/2017] [Indexed: 11/16/2022] Open
Abstract
Below the melting temperature Tm, crystals are the stable phase of typical elemental or molecular systems. However, cooling down a liquid below Tm, crystallization is anything but inevitable. The liquid can be supercooled, eventually forming a glass below the glass transition temperature Tg. Despite their long lifetimes and the presence of strong barriers that produces an apparent stability, supercooled liquids and glasses remain intrinsically a metastable state and thermodynamically unstable towards the crystal. Here we investigated the isothermal crystallization kinetics of the prototypical strong glassformer GeO2 in the deep supercooled liquid at 1100 K, about half-way between Tm and Tg. The crystallization process has been observed through time-resolved neutron diffraction for about three days. Data show a continuous reorganization of the amorphous structure towards the alpha-quartz phase with the final material composed by crystalline domains plunged into a low-density, residual amorphous matrix. A quantitative analysis of the diffraction patterns allows determining the time evolution of the relative fractions of crystal and amorphous, that was interpreted through an empirical model for the crystallization kinetics. This approach provides a very good description of the experimental data and identifies a predator-prey-like mechanism between crystal and amorphous, where the density variation acts as a blocking barrier.
Collapse
Affiliation(s)
- M Zanatta
- Dipartimento di Informatica, Università di Verona, I-37134 Verona, Italy.,ISC-CNR c/o Dipartimento di Fisica, Sapienza Università di Roma, I-00185 Roma, Italy
| | - L Cormier
- Institut de Minéralogie, de Physique des Matériaux, et de Cosmochimie (IMPMC), Sorbonne Universités, UPMC Université Paris 06, CNRS UMR 7590, Muséum National d'Histoire Naturelle, IRD UMR 206, F-75005 Paris, France
| | - L Hennet
- Conditions Extrêmes et Matériaux: Haute Température et Irradiation, CEMHTI-CNRS, Université d'Orléans, F-45071 Orléans, France.,Laboratoire Léon Brillouin, CEA-CNRS, CEA Saclay, F-91191 Gif sur Yvette, France
| | - C Petrillo
- Dipartimento di Fisica e Geologia, Università di Perugia, I-06123 Perugia, Italy.,IOM-CNR c/o Dipartimento di Fisica e Geologia, Università di Perugia, I-06123 Perugia, Italy
| | - F Sacchetti
- Dipartimento di Fisica e Geologia, Università di Perugia, I-06123 Perugia, Italy.,IOM-CNR c/o Dipartimento di Fisica e Geologia, Università di Perugia, I-06123 Perugia, Italy
| |
Collapse
|
24
|
Brunet L, Garnier N, Lejeune C, Mourey E, Cormier L, Fagnoni P, Guenfoudi M. Photovaporisation prostatique au laser Greenlight® : comparaison des couts (microcosting) et des recettes (t2a). Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Pradere B, Peyronnet B, Manach Q, Delporte G, Khene Z, Moulin M, Benoit T, Cormier L, Rizk J, Brichart N, Beauval J, Méjean A, Bex A, Roupret M, Bruyère F, Bensalah K. Néphrectomie partielle ouverte vs. robot assistée pour tumeurs kystiques : impact de la rupture de kyste peropératoire et résultats oncologiques. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Pradere B, Peyronnet B, Delporte G, Manach Q, Khene Z, Moulin M, Cormier L, Benoit T, Brichart N, Rizk J, Beauval J, Méjean A, Bex A, Roupret M, Bensalah K, Bruyère F. Résultats périopératoires des voies d’abord ouverte et robot assistée dans les néphrectomies partielles pour tumeurs kystiques : étude multicentrique internationale. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
27
|
Renard-Penna R, Rouvière O, Puech P, Borgogno C, Abbas L, Roy C, Claudon M, Correas JM, Cormier L, Ploussard G, Mejean A, Tezenas-du-Montcel S, Rozet F. Current practice and access to prostate MR imaging in France. Diagn Interv Imaging 2016; 97:1125-1129. [PMID: 27451262 DOI: 10.1016/j.diii.2016.06.010] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2016] [Revised: 06/18/2016] [Accepted: 06/23/2016] [Indexed: 01/09/2023]
Abstract
PURPOSE To obtain an overview of the degree of discrepancy between current clinical practice of prostate magnetic resonance imaging (MRI) in France and recommendations. MATERIALS AND METHODS A brief survey was sent to 1229 members of the French society of urology in order to identify their indications of prostate MRI and its impact on patient management. The urologists were asked to answer several questions regarding age, practice modality, prostate MRI examinations (technique, indication before first biopsy, second biopsy, cancer staging, active surveillance, recurrence, focal therapy) and quality of reports. RESULTS A total of 445 responses were received (participation rate of 36%). The mean delay for obtaining an appointment for prostate MRI ranged between 15-30 days in 54%. Fifty-four percent of MRI reports contained a PIRADS score and 23% a Likert score. The indications of multiparametric-MRI were tumor detection/location prior to repeat biopsy (90%), cancer staging (85%), management of patients under active surveillance (85%), selection of candidates to focal therapy (63%), tumor detection/location in biopsy naïve patients (53%), detection of local recurrence after radical (51%). Only 119 urologists (28.6%) had access to image fusion (MRI and transrectal ultrasound) and 351 (85.4%) used cognitive fusion. Mostly, targeted biopsies are done by urologists alone (nearly 80%), a very few are done by radiologists (8%) or by the two of them in collaboration (12%). CONCLUSION The majority of urologists consider that prostate MRI is essential for the management of patients with prostate cancer. Practices are ahead of recommendations particularly before the first biopsy and in active surveillance.
Collapse
Affiliation(s)
- R Renard-Penna
- Department of radiology, hôpital Tenon, Pitié-Salpétrière hospital, AP-HP, GRC n(o) 5, ONCOTYPE-URO, institut universitaire de cancérologie, UPMC université Paris 06, 83, boulevard de l'Hôpital, 75013 Paris, France.
| | - O Rouvière
- Hospices civils de Lyon, department of urinary and vascular radiology, hôpital Édouard-Herriot, 69437 Lyon, France; Faculté de médecine Lyon Est, université de Lyon, université Lyon 1, 69003 Lyon, France
| | - P Puech
- Department of radiology, Inserm, university de Lille, U1189 - ONCO-THAI - Image assisted laser therapy for oncology, CHU de Lille, 59000 Lille, France
| | - C Borgogno
- Department of urology, René-Dubos hospital, 95300 Pontoise, France
| | - L Abbas
- AP-HP, Pitié-Salpétrière hospital, department of biostatistics, public health and medical information, 75013 Paris, France; Sorbonne université, UPMC université-Paris 06 UMR_S1136, Inserm UMR_S 1136, institut Pierre-Louis d'épidémiologie et de Santé publique, 75013 Paris, France
| | - C Roy
- Department of radiology B, universitary hospital of Strasbourg, Civil hospital, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France
| | - M Claudon
- Department of radiology adults, Brabois hospital, university of Nancy, rue du Morvan, 54511 Vandœuvre-lès-Nancy, France
| | - J-M Correas
- Department of radiology, hospital Necker, 75015 Paris, France
| | - L Cormier
- Bourgogne university, academic department of urology, 21000 Dijon, France
| | - G Ploussard
- Department of urology, Saint-Louis hospital, Assistance publique-Hôpitaux de Paris, université Paris Diderot, Paris 7, Sorbonne Paris Cité, Paris, France
| | - A Mejean
- AP-HP, HEGP academic department of urology, 75007 Paris, France
| | - S Tezenas-du-Montcel
- AP-HP, Pitié-Salpétrière hospital, department of biostatistics, public health and medical information, 75013 Paris, France; Sorbonne université, UPMC université-Paris 06 UMR_S1136, Inserm UMR_S 1136, institut Pierre-Louis d'épidémiologie et de Santé publique, 75013 Paris, France
| | - F Rozet
- Montsouris institute, urology department, 75014 Paris, France
| |
Collapse
|
28
|
Malbranche C, Richard T, Beye F, Cormier L, Guignard MH, Fagnoni P, Lazzarotti A. La sécurisation par l’informatisation des prescriptions : les médicaments administrés sont-ils ceux prescrits ? ACTA ACUST UNITED AC 2016. [DOI: 10.1016/j.phclin.2015.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
29
|
Leclers F, Dutheil V, Poupot D, Moalic R, Gosseine PN, Cormier L, Bierman D. [Half-day case robotic radical prostatectomy. Surgery of the future? A case report]. Prog Urol 2015; 26:10-3. [PMID: 26586637 DOI: 10.1016/j.purol.2015.10.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Revised: 09/15/2015] [Accepted: 10/06/2015] [Indexed: 11/26/2022]
Abstract
INTRODUCTION Robotics and ambulatory are modern applications of surgery. This case study proves the feasibility of robot-assisted radical prostatectomy as an outpatient procedure. METHOD This report highlights the first, half-day, robotic prostatectomy performed on a 57-year-old man with localized prostate cancer. This operation was proposed to the subject because of his excellent physical condition and favorable environmental factors. He chose to undergo the surgery voluntarily. He underwent a nerve sparing radical prostatectomy. Target-controlled infusion propofol was used in perioperative sedation and analgesia. Postoperative evaluation criteria was made with the Visual Analog Scale of Pain Intensity (VASPI), Chung score and a patient satisfaction survey. RESULTS No perioperative or postoperative complications were reported. Blood loss was low (75 mL). The patient stayed less than 12 hours in the ambulatory unit thanks to a rapid recovery. The patient returned home after reporting a Chung score of 10. No hospital readmission was necessary. Functional results were: a bowel movement on day 1, back to work on day 2, normal urinary continence on day 8, a correct erectile function on day 9. Oncological results revealed negative surgical margins for cancer and PSA postoperative<0.03 ng/mL. CONCLUSION Ambulatory robotic radical prostatectomies can be performed on voluntarily-selected patients without affecting the high quality of urological surgery outcomes.
Collapse
Affiliation(s)
- F Leclers
- Service de chirurgie urologique, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France.
| | - V Dutheil
- Département d'anesthésie-réanimation, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France
| | - D Poupot
- Département d'anesthésie-réanimation, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France
| | - R Moalic
- Service de chirurgie urologique, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France
| | - P-N Gosseine
- Service de chirurgie urologique, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France
| | - L Cormier
- CHU de Dijon, 1, boulevard Jeanne-d'Arc, 21000 Dijon, France; Comité de cancérologie de l'AFU, 75000 Paris, France
| | - D Bierman
- Département d'anesthésie-réanimation, clinique Alpes-Belledonne, 31, rue Alexandre-Dumas, 38000 Grenoble, France
| |
Collapse
|
30
|
Hennequin C, Richaud P, Roca L, Silva M, Latorzeff I, Beckendorff V, Carrie C, Benyoucef A, Hasbini A, Supiot S, Ronchin P, Wachter T, Azria D, Cailleux P, Cormier L, Habibian M, Delaroche G. Randomized Phase 3 Trial of Dose Escalation (80 vs 70 Gy) in High-Risk Prostate Cancers Combined With Long-term Androgen Deprivation: GETUG-AFU 18 Trial, Acute and 1-Year Toxicities. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.107] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Thouant M, Bertaut A, Pommier P, Maingon P, Martin E, Quivrin M, Vulquin N, Ladoire S, Cormier L, Carrie C, Crehange G. Which PSA Endpoint Best Predicts Disease-Free Survival in Prostate Cancer Patients Treated With Exclusive Radiation Therapy Combined With Hormones? Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Laclergerie F, Mouillet G, Larre S, Eschwege P, Hubert J, Saussine C, Cormier L, Thiery-Vuillemin A, Kleinclauss F. Énucléation versus orchidectomie totale dans la prise en charge des tumeurs testiculaires à cellules de Leydig : résultats d’une étude multicentrique rétrospective. Prog Urol 2015; 25:855-6. [DOI: 10.1016/j.purol.2015.08.281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
33
|
Barbier V, Hardy J, Kanoun S, Cochet A, Arnould L, Crehange G, Cormier L. Les biopsies des vésicules séminales restent indispensables à l’ère de l’IRM et du TEP à la choline pour la prise en charge des récidives après radiothérapie ou curiethérapie pour cancer de la prostate. Prog Urol 2015; 25:733. [DOI: 10.1016/j.purol.2015.08.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Léon P, Kloutidis N, Calves J, Compérat E, Funes de la Vega M, Cancel Tassin G, Ciofu C, Haab F, Fournier G, Korman P, Valeri A, Rouprêt M, Cormier L, Larré S, Cussenot O. [Not Available]. Prog Urol 2015; 24:784. [PMID: 26461534 DOI: 10.1016/j.purol.2014.08.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- P Léon
- Service d'urologie et andrologie, hôpital de la Pitié-Salpêtrière, Paris, France
| | - N Kloutidis
- Service d'urologie, CHU de Dijon, Dijon, France
| | - J Calves
- Service d'urologie, CHU de Brest, Brest, France
| | - E Compérat
- Service d'anatomopathologie, hôpital de la Pitié-Salpêtrière, CeRePP, Paris, France
| | | | - G Cancel Tassin
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - C Ciofu
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - F Haab
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - G Fournier
- Service d'urologie du CHU de Brest et CeRePP, Brest, France
| | - P Korman
- Myriad Genetics SAS, Issy les Moulineaux, France
| | - A Valeri
- Service d'urologie du CHU de Brest et CeRePP, Brest, France
| | - M Rouprêt
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| | - L Cormier
- Service d'urologie, CHU de Dijon, CeRePP, Dijon, France
| | - S Larré
- Service d'urologie, CHU de Reims, CeRePP, Reims, France
| | - O Cussenot
- GRC-N(o)5 Institut universitaire de cancérologie Paris 6 (urologie-anatomo-pathologie Pitié/Tenon), CeReSPP, Paris, France
| |
Collapse
|
35
|
Rozet F, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Renard-Penna R, Richaud P, Salomon L, Soulié M. Prise en charge des tumeurs de la prostate à faible risque évolutif. Prog Urol 2015; 25:1-10. [DOI: 10.1016/j.purol.2014.10.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2014] [Revised: 10/10/2014] [Accepted: 10/18/2014] [Indexed: 11/15/2022]
|
36
|
Moulin M, Fourcade A, Phan Q, Mege J, Valeri A, Mourey E, Fournier G, Cormier L. Comparaison des résultats de prédiction du risque d’envahissement ganglionnaire du score de Roach et des tables de Partin : étude multicentrique. Prog Urol 2014; 24:785. [DOI: 10.1016/j.purol.2014.08.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Loffroy R, Pottecher P, Cherblanc V, Favelier S, Estivalet L, Koutlidis N, Moulin M, Cercueil J, Cormier L, Krausé D. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage. Diagn Interv Imaging 2014; 95:1027-34. [DOI: 10.1016/j.diii.2014.03.008] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Créhange G, Roach M, Martin É, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung H. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: Who, when, where and how? Cancer Radiother 2014; 18:524-34. [PMID: 25192626 DOI: 10.1016/j.canrad.2014.07.153] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Accepted: 07/29/2014] [Indexed: 11/26/2022]
|
39
|
Cochet A, Kanoun S, Humbert O, Walker PM, Cormier L, Créhange G, Brunotte F. Quelle imagerie pour la prise en charge de la rechute biochimique du cancer de la prostate : TEP ou IRM ? Cancer Radiother 2014; 18:509-16. [DOI: 10.1016/j.canrad.2014.07.148] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Revised: 07/15/2014] [Accepted: 07/16/2014] [Indexed: 12/25/2022]
|
40
|
Peyronnet B, Pradere B, Brichart N, Bodin T, Bertrand P, Bruyère F, Atassi A, Benmeziani R, Bodin T, Breque M, Brichart N, Bron J, Bruyere F, Cloche P, Corbel L, Cormier L, Cuvelier G, Delporte G, Fennouri M, Ferhi K, Fournier G, Gabbay G, Hurtes X, Laplace B, Le Gal S, Lecouteux A, Lesur G, Lokmane M, Mathieu R, Metois P, Miaadi N, Misrai V, Moreau J, Mouly P, Muyshondt C, Obringer L, Perrouin-Verbe M, Peyronnet B, Pradere B, Prezelin Y, Rigaud P, Salin A, Tabchouri N, Tanchoux C, Theveniaud P, Thoulouzan M, Thuillier C, Verhoest G. Complications Associated With Photoselective Vaporization of the Prostate: Categorization by a Panel of GreenLight Users According to Clavien Score and Report of a Single-center Experience. Urology 2014; 84:657-64. [DOI: 10.1016/j.urology.2014.05.028] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2014] [Revised: 05/21/2014] [Accepted: 05/23/2014] [Indexed: 11/16/2022]
|
41
|
Cormier L, Bastide C, Beuzeboc P, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Richaud P, Rozet F, Soulié M, Salomon L. [Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)]. Prog Urol 2013; 24:334-45. [PMID: 24821555 DOI: 10.1016/j.purol.2013.11.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Revised: 10/27/2013] [Accepted: 11/11/2013] [Indexed: 01/04/2023]
Abstract
OBJECTIVE Literature showed the impact of surgical margin status on prognosis after radical prostatectomy (mostly on biochemical survival). Margin status is an easy self-evaluation of surgical practice to assess. The aim of this paper was to define what a positive surgical margin (PSM) is and how to prevent the occurrence, to precise the impact on survival and how to treat. METHOD A literature analysis with Pubmed has been performed to 2012, furthermore conclusions of the main congresses with selection committee and review publication have also been studied. RESULTS PSM is defined as "tumor cells touching the ink on the specimen edge". The most frequent reported incidence is between 15 to 20%. Margin status remains one of the major criteria to determine the need of adjuvant radiotherapy after surgery. Quality of life is not or only lightly modified by radiotherapy with the current techniques. Adjuvant radiotherapy improves biological survival but is synonymous with overtreatment in many times. Salvage radiotherapy has to be quickly performed after Prostate Specific Antigen (PSA) relapse (PSA<1 ng/mL even<0.5 ng/mL). CONCLUSION This literature review did not allow to suggest superiority of one surgical technique over another. In the same way, the kind of dissection i.e. bladder neck or neurovascular bundle preservation does no clearly modify PSM rate. However, it seems logical to "customize" dissection according to prostate cancer characteristics (D'Amico criteria for instance) guided with multiparametric MRI. Intrafascial dissection has to be applied only to low risk. Lastly, the debate between adjuvant or salvage radiotherapy is always ongoing.
Collapse
Affiliation(s)
- L Cormier
- Sous-comité « prostate » du CCAFU, hôpital du Bocage, CHU de Dijon, 14, rue Gaffarel, BP 77908, 21079 Dijon cedex, France.
| | - C Bastide
- Sous-comité « prostate » du CCAFU, CHU de Marseille, 13015 Marseille, France.
| | - P Beuzeboc
- Sous-comité « prostate » du CCAFU, institut Curie, 75248 Paris, France.
| | - G Fromont
- Sous-comité « prostate » du CCAFU, CHU de Tours, 37044 Tours, France.
| | - C Hennequin
- Sous-comité « prostate » du CCAFU, CHU Saint-Louis, 75475 Paris, France.
| | - P Mongiat-Artus
- Sous-comité « prostate » du CCAFU, CHU Saint-Louis, 75475 Paris, France.
| | - M Peyromaure
- Sous-comité « prostate » du CCAFU, CHU de Cochin, 75014 Cochin, France.
| | - G Ploussard
- Sous-comité « prostate » du CCAFU, CHU Saint-Louis, 75475 Paris, France.
| | - R Renard-Penna
- Sous-comité « prostate » du CCAFU, CHU La Pitié, 75013 Paris, France.
| | - P Richaud
- Sous-comité « prostate » du CCAFU, institut Bergonié, 33076 Bordeaux, France.
| | - F Rozet
- Sous-comité « prostate » du CCAFU, institut Monstsouris, 75014 Paris, France.
| | - M Soulié
- Sous-comité « prostate » du CCAFU, CHU de Toulouse, 31403 Toulouse, France.
| | - L Salomon
- Sous-comité « prostate » du CCAFU, CHU Mondor, 94010 Paris, France.
| | | |
Collapse
|
42
|
Largeron J, Duperron C, Cormier L, Descotes J, Boiteux J, Guy L. L’IRM 3Tesla multiparametrique dans le staging du cancer de prostate en fonction du delai entre les biopsies et l’IRM. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.08.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Salomon L, Bastide C, Beuzeboc P, Cormier L, Fromont G, Hennequin C, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Rozet F, Azria D, Coloby P, Molinié V, Ravery V, Rebillard X, Richaud P, Villers A, Soulié M. Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate. Prog Urol 2013; 23 Suppl 2:S69-101. [DOI: 10.1016/s1166-7087(13)70048-4] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
44
|
Boissier R, Descotes JL, Oudard S, Cormier L, Krakowski I, Houédé N, Albigès L. Erratum à « Cancer de prostate et optimisation de la prise en charge multidisciplinaire : le point sur le RCP, et la prise en charge du cancer de prostate résistant à la castration » [Prog. Urol. 23 (HS4) (2013) 7–12]. Prog Urol 2013. [DOI: 10.1016/j.purol.2013.07.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
45
|
Hennequin C, Cormier L, Richaud P, Bastide C, Beuzeboc P, Fromont G, Mongiat-Artus P, Peyromaure M, Ploussard G, Renard-Penna R, Rozet F, Soulié M, Salomon L. Curiethérapie exclusive du cancer de la prostate par implants permanents : indications et résultats. Revue du CC-AFU. Prog Urol 2013; 23:378-85. [DOI: 10.1016/j.purol.2012.12.006] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2012] [Revised: 12/12/2012] [Accepted: 12/14/2012] [Indexed: 11/27/2022]
|
46
|
Bernigaud C, Bel B, Aubriot-Lorton MH, Cormier L, Dalac-Rat S, Vabres P. Métastases cutanées péniennes révélatrices d’un adénocarcinome de prostate. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
47
|
Crehange G, Gauthier M, Ladoire S, Mirjolet C, Cormier L, Khoury C, Truc G, Peignaux-Casasnovas K, Martin E, Maingon P. Duration of Androgen Deprivation Combined With Radiation Therapy Does Not Jeopardize Time to Castration Resistance in Men With Unfavorable Intermediate- and High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Phan QB, Koutlidis N, Duperron C, Castaings T, Mourey E, Michel F, Cormier L. Morbidité du curage ganglionnaire étendu par chirurgie robot-assistée lors de la prostatectomie totale. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
49
|
Largeron J, Duperron C, Alfidja A, Cormier L, Descotes JL, Boiteux JP, Guy L. L’IRM 3 Tesla multiparametrique en pratique courante dans le bilan d’extension du cancer de prostate localisé : étude multicentrique. Prog Urol 2012. [DOI: 10.1016/j.purol.2012.08.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
50
|
Eschwège P, Gaschignard N, Ploussard G, Peyromaure M, Bastide C, Cormier L, Mongiat-Artus P, Rozet F, Fromont G, Hennequin C, Renard-Penna R, Beuzeboc P, Richaud P, Soulié M, Salomon L. Inhibiteurs des 5 alpha-réductases et cancer de la prostate : une mise au point du Comité de cancérologie de l’Association française d’urologie. Prog Urol 2012; 22:555-60. [DOI: 10.1016/j.purol.2012.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Revised: 04/10/2012] [Accepted: 04/12/2012] [Indexed: 10/28/2022]
|